RNAZ · Categories · Form 4

RNAZ - SEC Form 4 insider transactions

TransCode Therapeutics Inc. (RNAZ) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RNAZ

• 677d
  SEC Form 4 filed by Director Marquet Magda

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 677d
  SEC Form 4 filed by Director Manting Erik

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 677d
  SEC Form 4 filed by Interim CEO, CFO Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 677d
  SEC Form 4 filed by Director Calais Philippe

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1039d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1047d
  SEC Form 4 filed by Dudley Robert Michael (Amendment)

  4/A - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1048d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Manting Erik

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Marquet Magda

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1072d
  SEC Form 4 filed by Calais Philippe

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1082d
  SEC Form 4 filed by Manting Erik

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1082d
  SEC Form 4 filed by Marquet Magda

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1082d
  SEC Form 4 filed by Calais Philippe

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1228d
  SEC Form 4 filed by Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1228d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1228d
  SEC Form 4 filed by Medarova Zdravka

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1228d
  SEC Form 4 filed by Medarova Zdravka

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1317d
  SEC Form 4: Dudley Robert Michael bought $23,000 worth of shares (20,000 units at $1.15), increasing direct ownership by 2% to 893,114 units

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1403d
  SEC Form 4 filed by Calais Philippe

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1403d
  SEC Form 4 filed by Marquet Magda

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1403d
  SEC Form 4 filed by Manting Erik

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1409d
  SEC Form 4: Fitzgerald Thomas A bought $15,240 worth of shares (12,000 units at $1.27), increasing direct ownership by 9% to 139,377 units

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1425d
  SEC Form 4: Dudley Robert Michael bought $55,383 worth of shares (30,000 units at $1.85), increasing direct ownership by 4% to 873,114 units

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1515d
  SEC Form 4 filed by Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1543d
  SEC Form 4 filed by Fitzgerald Thomas A

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)
• 1543d
  SEC Form 4 filed by Dudley Robert Michael

  4 - Transcode Therapeutics, Inc. (0001829635) (Issuer)

Other RNAZ categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends